|
|
|
(State of
|
(Commission
|
(I.R.S. Employer
|
incorporation)
|
File Number)
|
Identification Number)
|
|
|
(Address of principal executive offices) (Zip code)
|
(
|
(Registrant’s telephone number, including area code)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading symbol(s)
|
Name of each exchange on which registered
|
||
|
|
|
Date: April 18, 2024
|
By:
|
/s/ James R. Gruber
|
James R. Gruber
|
||
Chief Financial Officer and Secretary
|
||
(Principal Financial Officer)
|
Document And Entity Information |
Apr. 15, 2024 |
---|---|
Document Information [Line Items] | |
Entity, Registrant Name | ETON PHARMACEUTICALS, INC. |
Document, Type | 8-K |
Document, Period End Date | Apr. 15, 2024 |
Entity, Incorporation, State or Country Code | DE |
Entity, File Number | 001-38738 |
Entity, Tax Identification Number | 37-1858472 |
Entity, Address, Address Line One | 21925 W. Field Parkway, Suite 235 |
Entity, Address, City or Town | Deer Park |
Entity, Address, State or Province | IL |
Entity, Address, Postal Zip Code | 60010 |
City Area Code | 847 |
Local Phone Number | 787-7361 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock |
Trading Symbol | ETON |
Security Exchange Name | NASDAQ |
Entity, Emerging Growth Company | false |
Amendment Flag | false |
Entity, Central Index Key | 0001710340 |
-8?20$3;8T.P6BP^0"X99K>]9!:G
-\\AI$(XS-Y;A#9DZ;G;,9 @